Abstract
Human infection with the rat lungworm, Angiostrongylus cantonensis, is characterized by a vigorous eosinophil response that gives the disease its name, eosinophilic meningitis. The actual role eosinophils play, both protective and destructive, in this infectious process is still largely a mystery. Research since 2002 has indicated that eosinophils are a multifaceted granulocyte that contributes to a wide range of physiological and pathological processes depending on their location and activation status. This article suggests an expanded role for eosinophils as both classic antiparasitic effector cells and as immune regulatory cells in eosinophilic meningitis caused by Angiostronglyus cantonensis.
Keywords: Angiostrongylus cantonensis, Cerebrospinal fluid, Eosinophilia, Food, Immunology, Meningitis, Parasitology
Background
Dr Paul Ehrlich, using a newly discovered dye, eosin, discovered eosinophils in the blood of humans and other animals in 1879. The cells were named eosinophilic granulocytes because of their reddish orange staining properties.1 Eosin binds highly basic proteins that constitute the granules of these cells. These granules can be classified into four different populations: crystalloid granules, primary granules, small granules, and secretory vesicles. The largest are the crystalloid granules that store the majority of granule proteins in eosinophils. These granules contain an array of cationic proteins, designated major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), and eosinophil-derived neurotoxin (EDN), and are arranged as a crystalloid core consisting of MBP-1 (and MBP-2) and a matrix of the ECP, EDN, and EPO proteins. Differential release of these proteins is mediated by directed exocytosis and degranulation.2,3
Search Strategy and Selection Criteria
For this short review, PubMed was searched for reports published in English between May 2002 and May 2012 with the search terms “eosinophil,” “eosinophilic meningitis,” and “Angiostronglyus cantonensis.” Although publications from the past ten years were mainly selected, commonly referenced and highly regarded previous publications were not excluded. Reference lists of articles identified by this search strategy were also searched and relevant reports selected.
Function
Most eosinophils in the human body are distributed in the mucosal tissues and the classical view of eosinophil function is that they are terminally differentiated granulocytes primarily involved with either the destruction of helminthic pathogens, such as intestinal and tissue nematodes and schistosomes, or associated with the disease process of allergic diseases, such as asthma.3 Since 2002 this narrow view of eosinophil function has given way to a broader concept of the role eosinophils play in the maintenance of immune homeostasis, in part because of the production of a wide range of diverse proinflammatory and regulatory cytokines and chemokines and functions such as antigen presentation.4,5 This evolving role for eosinophils in the host immune response has these cells capable of both an effector function as well as participating in tissue repair and immunoregulation.6
Disease Process
Human disease with the rat lungworm, Angiostrongylus cantonensis, is associated with three main clinical entities, meningitis, encephalitis, and ocular involvement because of the presence of the organisms in these tissues.7–9 The initial infectious process begins with ingestion of infective third stage larvae (L3) that penetrate the gut lumen. This allows the parasites to enter the circulatory system where they eventually gain access to the central nervous system (CNS).9 The presence of the parasites in the CNS results in a clinical syndrome characterized by eosinophils in the cerebrospinal fluid (CSF).10 While there are a number of different etiologies for eosinophilic meningitis, the most common infectious cause is A. cantonensis.11 The predominant clinical feature of eosinophilic meningitis due to A. cantonensis is headache followed by development of a variety of meningeal signs and symptoms that include neck pain/stiffness, fever, nausea, and vomiting.12,13 Imaging studies, such as magnetic resonance imaging (MRI), of patients with eosinophilic meningitis have demonstrated abnormalities in many but not all patients. These abnormalities, while not pathognomonic for this infection, tended to present as single or multiple enhancing lesions of the leptomeninges and parenchyma of the brain.14,15 These changes have been attributed to the migration of the parasite, inflammation, or granuloma formation from dead or dying worms.12,13,15,16
Eosinophilic meningitis is generally a self-limiting disease12 with mortality rates reported to be less than 1%11,17 so necropsy studies of human angiostrongyliasis are limited. Published autopsy and subsequent pathologic studies of fatal cases generally show the following features: (1) meningeal infiltration by eosinophils, macrophages, and lymphocytes, (2) distinct tracks within the brain parenchyma associated with cell debris, (3) microthrombi and inflammatory cells that are assumed to be due to the migration of the parasite, and (4) the presence of classic granulomatas surrounding dead worms. Histologically a large numbers of eosinophils have been associated with meningeal infiltration and the granuloma formation but perhaps surprisingly not in close association with viable or well preserved larval worms as would be expected for a direct role in parasite killing.18–20
Eosinophilic Response
Understanding of the role eosinophils play in the human immune response to helminthic pathogens is far from complete.21 Work since 2002 to further elucidate the immunobiology of eosinophils has led to consideration of a broader role for these cells in immunity to helminthic infections.22,23 The classical view of eosinophils as solely effector cells for parasite killing has given way to the idea that these cells play important roles in regulation of cellular immune responses.24 Eosinophils could be envisioned to have a number of different functions in response to A. cantonensis infections. An example of this diverse functionality can be illustrated in the formation of granulomas around dead or dying A. cantonensis larvae. Similar to granulomas observed with schistosomiasis, granulomas in angiostrongyliasis contain large numbers of activated eosinophils that produce TH2-associated cytokines that drive granuloma development.25 In vitro work involving interleukin 5 (IL-5) knockout mice suggested that eosinophils are involved in the direct killing of the intracranial worms.26 While a recent mouse study found that blocking the CCR3 chemokine receptor, which is abundant on the surface of eosinophils and is responsible for their activation and chemotaxis, did not affect worm burden as a result of decreasing the number of intracranial eosinophils.27 Whether these findings can be translated to humans remains to be elucidated,6 as it is crucial to keep in mind the immunological differences between species and to consider such when applying mouse models to the mechanism of human disease. Presently there is sparse evidence in the literature to directly support the idea of eosinophils participating in the direct killing of A. cantonensis larvae in the CNS. Therefore it is equally likely that the recruitment of eosinophils into the brain parenchyma may occur secondarily as a result of parasite death.
Expanded Role for Eosinophils in Eosinophilic Meningitis
It is possible to speculate that the central function of eosinophils may be in tissue remodeling, repair, and, more importantly, immuno-regulation. It is interesting to note that eosinophils express two cytokines: interleukin 12 (IL-12) and gamma interferon (IFN-γ), both of which serve to down regulate TH2 type inflammatory responses. Indeed, IL-12 has been shown to inhibit allergen-induced TH2 cytokine responses and eosinophil degranulation.3 This suggests that eosinophils may have the ability to release cytokines that regulate eosinophil modulated TH2 type tissue inflammation resulting from migrating parasites.4 Eosinophils (as well as other immune cells such as T-cells) have also been shown to store, produce, and release neurotrophins such as brain-derived neurotrophic factor (BDNF).28,29 It has been suggested that locally produced BDNF in the CNS mitigates inflammation-dependent neuronal damage.30 Furthermore it could be hypothesized that the pathology of human angiostrongyliasis may be due in part to the inability of eosinophils to modulate TH2 type effector functions such as granuloma formation and inflammation initiated by the migration, death, and disintegration of the A. cantonensis larvae. This inability of the eosinophil population to modulate the host inflammatory response may be due to host factors such as polymorphisms in eosinophil cytokine receptor expression, parasite factors such as strain variations in A. cantonensis, or a combination of both. Further studies are required to truly appreciate the role eosinophils play in disease associated with human Angiostrongylus cantonensis infection.
Conclusion
Understanding of the function of eosinophils has significantly increased over the past few years. However, more research is needed to define their role in Angiostrongylus cantonensis infections. Only by understanding this intricate biological role that eosinophils play in eosinophilic meningitis can rational treatment protocols be proposed and tested.
Acknowledgements
This paper represents a contribution to the Rat Lungworm Disease Scientific Workshop held at the Ala Moana Hotel, Honolulu, Hawa‘i in August 2011. Funding for the workshop and for this publication was provided by the National Institute of Food and Agriculture, United States Department of Agriculture, through Award No. 2011-65213-29954.
Conflict of Interest
Neither author identifies any conflict of interest.
References
- 1.Hirsch JG, Hirsch BI. Paul Ehrlich and the discovery of the eosinophil. In: Mahmoud AAF, Austen KF, editors. The Eosinophil in Health and Disease. New York: Grune & Stratton; 1980. pp. 3–23. [Google Scholar]
- 2.Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24:147–174. doi: 10.1146/annurev.immunol.24.021605.090720. [DOI] [PubMed] [Google Scholar]
- 3.Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38(5):709–750. doi: 10.1111/j.1365-2222.2008.02958.x. [DOI] [PubMed] [Google Scholar]
- 4.Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev. 2011;242(1):161–177. doi: 10.1111/j.1600-065X.2011.01026.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res. 2011;343(1):57–83. doi: 10.1007/s00441-010-1049-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol. 2007;119(6):1313–1320. doi: 10.1016/j.jaci.2007.03.043. [DOI] [PubMed] [Google Scholar]
- 7.Wang QP, Lai DH, Zhu XQ, Chen XG, Lun ZR. Human angiostrongyliasis. Lancet Infect Dis. 2008;8(10):621–630. doi: 10.1016/S1473-3099(08)70229-9. [DOI] [PubMed] [Google Scholar]
- 8.Wang QP, Wu ZD, Wei J, Owen RL, Lun ZR. Human Angiostrongylus cantonensis: an update. Eur J Clin Microbiol Infect Dis. 2012;31(4):389–395. doi: 10.1007/s10096-011-1328-5. [DOI] [PubMed] [Google Scholar]
- 9.Graeff-Teixeira C, da Silva AC, Yoshimura K. Update on eosinophilic meningoencephalitis and its clinical relevance. Clin Microbiol Rev. 2009;22(2):322–348. doi: 10.1128/CMR.00044-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sawanyawisuth K, Sawanyawisuth K, Senthong V, et al. How can clinicians ensure the diagnosis of meningitic angiostrongyliasis? Vector Borne Zoonotic Dis. 2012;12(1):73–75. doi: 10.1089/vbz.2011.0711. [DOI] [PubMed] [Google Scholar]
- 11.Lo Re V, 3rd, Gluckman SJ. Eosinophilic meningitis. Am J Med. 2003;114(3):217–223. doi: 10.1016/s0002-9343(02)01495-x. [DOI] [PubMed] [Google Scholar]
- 12.Tseng YT, Tsai HC, Sy CL, et al. Clinical manifestations of eosinophilic meningitis caused by Angiostrongylus cantonensis: 18 years' experience in a medical center in southern Taiwan. J Microbiol Immunol Infect. 2011;44(5):382–389. doi: 10.1016/j.jmii.2011.01.034. [DOI] [PubMed] [Google Scholar]
- 13.Hochberg NS, Blackburn BG, Park SY, Sejvar JJ, Effler PV, Herwaldt BL. Eosinophilic meningitis attributable to Angiostrongylus cantonensis infection in Hawaii: clinical characteristics and potential exposures. Am J Trop Med Hyg. 2011;85(4):685–690. doi: 10.4269/ajtmh.2011.11-0322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Jin E, Ma D, Liang Y, Ji A, Gan S. MRI findings of eosinophilic myelomeningoencephalitis due to Angiostrongylus cantonensis. Clin Radiol. 2005;60(2):242–250. doi: 10.1016/j.crad.2004.05.012. [DOI] [PubMed] [Google Scholar]
- 15.Jin EH, Ma Q, Ma DQ, He W, Ji AP, Yin CH. Magnetic resonance imaging of eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis following eating freshwater snails. Chin Med J. 2008. 5;121(1):67–72. [PubMed] [Google Scholar]
- 16.Batmanian JJ, O'Neill JH. Eosinophilic meningoencephalitis with permanent neurological sequelae. Intern Med J. 2004;34(4):217–218. doi: 10.1111/j.1444-0903.2004.00561.x. [DOI] [PubMed] [Google Scholar]
- 17.Punyagupta S, Juttijudata P, Bunnag T. Eosinophilic meningitis in Thailand. Clinical studies of 484 typical cases probably caused by Angiostrongylus cantonensis. Am J Trop Med Hyg. 1975;24:921–931. [PubMed] [Google Scholar]
- 18.Tangchai P, Nye SW, Beaver PC. Eosinophilic meningoencephalitis caused by angiostrongyliasis in Thailand. Autopsy report. Am J Trop Med Hyg. 1967;16(4):454–461. doi: 10.4269/ajtmh.1967.16.454. [DOI] [PubMed] [Google Scholar]
- 19.Kliks MM, Kroenke K, Hardman JM. Eosinophilic radiculomyeloencephalitis: an angiostrongyliasis outbreak in American Samoa related to ingestion of Achatina fulica snails. Am J Trop Med Hyg. 1982;31(6):1114–1122. doi: 10.4269/ajtmh.1982.31.1114. [DOI] [PubMed] [Google Scholar]
- 20.Lindo JF, Escoffery CT, Reid B, Codrington G, Cunningham-Myrie C, Eberhard ML. Fatal autochthonous eosinophilic meningitis in a Jamaican child caused by Angiostrongylus cantonensis. Am J Trop Med Hyg. 2004;70(4):425–428. [PubMed] [Google Scholar]
- 21.Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol. 2004;113(1):30–37. doi: 10.1016/j.jaci.2003.10.050. [DOI] [PubMed] [Google Scholar]
- 22.Anthony RM, Rutitzky LI, Urban JF, Jr, Stadecker MJ, Gause WC. Protective immune mechanisms in helminth infection. Nat Rev Immunol. 2007;7(12):975–987. doi: 10.1038/nri2199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths. Nat Rev Immunol. 2011;11(6):375–388. doi: 10.1038/nri2992. [DOI] [PubMed] [Google Scholar]
- 24.Gebreselassie NG, Moorhead AR, Fabre V, et al. Eosinophils preserve parasitic nematode larvae by regulating local immunity. J Immunol. 2012;188(1):417–425. doi: 10.4049/jimmunol.1101980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Rumbley CA, Sugaya H, Zekavat SA, El Refaei M, Perrin PJ, Phillips SM. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J Immunol. 1999;162(2):1003–1009. [PubMed] [Google Scholar]
- 26.Sugaya H, Aoki M, Yoshida T, Takatsu K, Yoshimura K. Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor alpha chain-knockout mice infected with Angiostrongylus cantonensis. Parasitol Res. 1997;83(6):583–590. doi: 10.1007/s004360050302. [DOI] [PubMed] [Google Scholar]
- 27.Chuang CC, Su KE, Chen CW, et al. Anti-CCR3 monoclonal antibody inhibits eosinophil infiltration in Angiostrongylus cantonensis-infected ICR mice. Acta Trop. 2010;113(3):209–213. doi: 10.1016/j.actatropica.2009.10.017. [DOI] [PubMed] [Google Scholar]
- 28.Noga O, Englmann C, Hanf G, Grützkau A, Seybold J, Kunkel G. The production, storage and release of the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics and non-allergics. Clin Exp Allergy. 2003;33(5):649–654. doi: 10.1046/j.1365-2222.2003.01586.x. [DOI] [PubMed] [Google Scholar]
- 29.Kerschensteiner M, Gallmeier E, Behrens L, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med. 1999;189(5):865–870. doi: 10.1084/jem.189.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Wekerle H, Hohlfeld R. Beneficial brain autoimmunity? Brain. 2010;133(8):2182–2184. doi: 10.1093/brain/awq206. [DOI] [PubMed] [Google Scholar]